S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)

R1 RCM (RCM) Stock Forecast, Price & News

$15.58
+0.50 (+3.32%)
(As of 09/22/2023 ET)
Compare
Today's Range
$14.98
$15.75
50-Day Range
$15.08
$18.49
52-Week Range
$6.71
$19.46
Volume
1.64 million shs
Average Volume
2.52 million shs
Market Capitalization
$6.53 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$19.11

R1 RCM MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.88 Rating Score
Upside/​Downside
22.6% Upside
$19.11 Price Target
Short Interest
Healthy
7.89% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.33
Upright™ Environmental Score
News Sentiment
0.75mentions of R1 RCM in the last 14 days
Based on 5 Articles This Week
Insider Trading
Selling Shares
$858,500 Sold Last Quarter
Proj. Earnings Growth
262.50%
From $0.08 to $0.29 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.75 out of 5 stars

Business Services Sector

58th out of 307 stocks

Management Services Industry

3rd out of 6 stocks


RCM stock logo

About R1 RCM (NASDAQ:RCM) Stock

R1 RCM Inc. provides technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and physician groups. It offers end-to-end revenue cycle management (RCM) services, which address the spectrum of revenue cycle challenges faced by healthcare providers. The company provides modular services, including physician advisory services, which assists healthcare organizations in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes; practice management services that offers administrative and operational support for patient care and outsource non-core functions; revenue integrity solutions, including coding management services, such as business intelligence and analysis, human capital management, accountability framework, and quality management programs; patient experience; and business office services. R1 RCM Inc. was founded in 2003 and is headquartered in Murray, Utah.

RCM Price History

RCM Stock News Headlines

R1 RCM Inc. sees growth despite trading at discount
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
Implied Volatility Surging for R1 RCM (RCM) Stock Options
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
Truist Financial Sticks to Its Hold Rating for R1 RCM (RCM)
RBC Capital Reaffirms Their Buy Rating on R1 RCM (RCM)
Robert W. Baird Keeps Their Buy Rating on R1 RCM (RCM)
R1 RCM Inc. (RCM) Reports Break-Even Earnings for Q2
R1 RCM Inc.: R1 RCM Reports Second Quarter 2023 Results
R1 RCM Reports Second Quarter 2023 Results
R1 RCM Q2 2023 Earnings Preview
6 Analysts Have This to Say About R1 RCM
Truist Financial Keeps Their Hold Rating on R1 RCM (RCM)
Bank of America Securities Remains a Buy on R1 RCM (RCM)
See More Headlines
Receive RCM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for R1 RCM and its competitors with MarketBeat's FREE daily newsletter.

RCM Company Calendar

Last Earnings
2/16/2023
Today
9/22/2023
Next Earnings (Estimated)
11/14/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Management services
Sub-Industry
Health Care Services
Current Symbol
NASDAQ:RCM
CUSIP
00438V10
Employees
27,800
Year Founded
2003

Price Target and Rating

Average Stock Price Forecast
$19.11
High Stock Price Forecast
$25.00
Low Stock Price Forecast
$10.00
Forecasted Upside/Downside
+22.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.88
Research Coverage
16 Analysts

Profitability

Net Income
$-57,600,000.00
Pretax Margin
-2.82%

Debt

Sales & Book Value

Annual Sales
$1.81 billion
Cash Flow
$0.28 per share
Book Value
$6.53 per share

Miscellaneous

Free Float
263,944,000
Market Cap
$6.53 billion
Optionable
Not Optionable
Beta
0.84

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • Mr. Lee RivasMr. Lee Rivas (Age 48)
    CEO & Director
    Comp: $1.12M
  • Mr. John M. SparbyMr. John M. Sparby (Age 47)
    Pres
    Comp: $656.99k
  • Ms. Jennifer Williams (Age 46)
    Exec. VP, CFO & Treasurer
  • Mr. Richard B. Evans Jr.Mr. Richard B. Evans Jr. (Age 55)
    Sr. VP, Corp. Controller & Chief Accounting Officer
  • Mr. Atif A. Rahim
    Sr. VP of Investor Relations & Bus. Devel.
  • Mr. Corey Perman
    Exec. VP of Compliance & Risk
  • Mr. Sean Radcliffe
    Exec. VP, Gen. Counsel & Corp. Sec.
  • Ms. Kate Sanderson
    Exec. VP & Chief HR Officer
  • Mr. David Strickle
    Exec. VP of Integration
  • Mr. Kyle A. Hicok (Age 43)
    Exec. VP & Chief Commercial Officer













RCM Stock - Frequently Asked Questions

Should I buy or sell R1 RCM stock right now?

16 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for R1 RCM in the last twelve months. There are currently 2 hold ratings and 14 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" RCM shares.
View RCM analyst ratings
or view top-rated stocks.

What is R1 RCM's stock price forecast for 2023?

16 Wall Street analysts have issued 12-month price targets for R1 RCM's shares. Their RCM share price forecasts range from $10.00 to $25.00. On average, they anticipate the company's stock price to reach $19.11 in the next year. This suggests a possible upside of 22.6% from the stock's current price.
View analysts price targets for RCM
or view top-rated stocks among Wall Street analysts.

How have RCM shares performed in 2023?

R1 RCM's stock was trading at $10.95 at the start of the year. Since then, RCM stock has increased by 42.3% and is now trading at $15.58.
View the best growth stocks for 2023 here
.

When is R1 RCM's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 14th 2023.
View our RCM earnings forecast
.

How were R1 RCM's earnings last quarter?

R1 RCM Inc. (NASDAQ:RCM) announced its quarterly earnings results on Thursday, February, 16th. The healthcare provider reported ($0.09) earnings per share for the quarter, missing the consensus estimate of ($0.03) by $0.06. The healthcare provider had revenue of $532.80 million for the quarter, compared to the consensus estimate of $519.28 million. R1 RCM had a negative net margin of 3.09% and a negative trailing twelve-month return on equity of 2.41%. The company's quarterly revenue was up 33.6% on a year-over-year basis. During the same period last year, the firm earned $0.11 EPS.

What guidance has R1 RCM issued on next quarter's earnings?

R1 RCM issued an update on its FY 2023 earnings guidance on Wednesday, August, 2nd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $2.25 billion-$2.27 billion, compared to the consensus revenue estimate of $2.31 billion.

What is Joseph Flanagan's approval rating as R1 RCM's CEO?

253 employees have rated R1 RCM Chief Executive Officer Joseph Flanagan on Glassdoor.com. Joseph Flanagan has an approval rating of 70% among the company's employees.

What other stocks do shareholders of R1 RCM own?

Based on aggregate information from My MarketBeat watchlists, some companies that other R1 RCM investors own include NVIDIA (NVDA), JD.com (JD), Baozun (BZUN), Inseego (INSG), BioXcel Therapeutics (BTAI), Marvell Technology (MRVL), Akoustis Technologies (AKTS), Alibaba Group (BABA), Bilibili (BILI) and Model N (MODN).

What is R1 RCM's stock symbol?

R1 RCM trades on the NASDAQ under the ticker symbol "RCM."

Who are R1 RCM's major shareholders?

R1 RCM's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (3.36%), Capital International Investors (1.96%), Bank of New York Mellon Corp (1.62%), Polar Capital Holdings Plc (1.12%), Snyder Capital Management L P (0.99%) and State Street Corp (0.98%). Insiders that own company stock include Achi Series Lllp Tcp-Asc, Alex Mandl, Gary Steven Long, John B Henneman III, John M Sparby, Joseph Gerard Flanagan, Lee Rivas and Richard B Jr Evans.
View institutional ownership trends
.

How do I buy shares of R1 RCM?

Shares of RCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is R1 RCM's stock price today?

One share of RCM stock can currently be purchased for approximately $15.58.

How much money does R1 RCM make?

R1 RCM (NASDAQ:RCM) has a market capitalization of $6.53 billion and generates $1.81 billion in revenue each year. The healthcare provider earns $-57,600,000.00 in net income (profit) each year or ($0.16) on an earnings per share basis.

How many employees does R1 RCM have?

The company employs 27,800 workers across the globe.

Does R1 RCM have any subsidiaries?
The following companies are subsidiares of R1 RCM: Accretive Health Mauritius Inc., Cerner RevWorks, Clearsight Intermediate Holdings Inc., Cloudmed, Flare Capital Partners Investment Company, Intermedix, Intermedix ARM LLC, Intermedix Corporation, Intermedix Holdings Inc., Intermedix Lietuva UAB, Intermedix Midco Inc., Intermedix Office Based LLC, Intermedix Staffing Inc., Medical Consultants Inc., Practice Support Resources LLC, Project Links Parent Inc., Project Roadrunner Merger Sub Inc., Project Roadrunner Parent Inc., R1 RCM Global Private Limited, R1 RCM India Private Limited, Rover16 Inc., SCHEDULING.COM INC., SCI Solutions, Tonic Health LLC, VisitPay, cGate Health Inc., and iVinci Partners LLC.
Read More
How can I contact R1 RCM?

R1 RCM's mailing address is 401 NORTH MICHIGAN AVENUE SUITE 2700, CHICAGO IL, 60611. The official website for the company is www.r1rcm.com. The healthcare provider can be reached via phone at (312) 324-7820, via email at arahim@r1rcm.com, or via fax at 302-655-5049.

This page (NASDAQ:RCM) was last updated on 9/22/2023 by MarketBeat.com Staff

My Account -